A retro-inverso peptide analogue of the FMDV VP1 GH loop provides enhanced, long-lasting immunogenicity and protection in a guinea pig model, suggesting utility for peptide vaccine design.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating for retro-inverso FMDV peptide vaccines; leaves open validation in natural hosts before any field use.
Peptides corresponding to the immunodominant loop located at residues 135-158 on capsid protein VP1 of foot-and-mouth disease virus (FMDV) generally elicit high levels of anti-peptide and virus-neutralizing antibodies. In some instances, however, the level of neutralizing antibodies is low or even negligible, even though the level of anti-peptide antibodies is high. We have shown previously that the antigenic activity of peptide 141-159 of VP1 of a variant of serotype A can be mimicked by a retro-inverso (all-D retro or retroenantio) peptide analogue. This retro-inverso analogue induced greater and longer-lasting antibody titers than did the corresponding L-peptide. We now show that a single inoculation of the retro-inverso analogue elicits high levels of neutralizing antibodies that persist longer than those induced against the corresponding L-peptide and confer substantial protection in guinea pigs challenged with the cognate virus. In view of the high stability to proteases of retro-inverso peptide analogues and their enhanced immunogenicity, these results have practical relevance in designing potential peptide vaccines.
No takes yet. Share an insight, caveat, or question.
Briand et al. (1997) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: